Terms: = Leukemia AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
18114 results:
1. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic leukemia in Mexico.
Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
[TBL] [Abstract] [Full Text] [Related]
2. Periorbital cellulitis as the initial presentation of acute lymphoblastic leukaemia.
Han-Menz C; Kozgar SAM; Rana MS
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749518
[TBL] [Abstract] [Full Text] [Related]
3. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract] [Full Text] [Related]
4. Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation.
Jiang Y; Feng D; Zhu J; Wei D; Zhao C; Liu H; Shao S; Wang C
Front Immunol; 2024; 15():1381308. PubMed ID: 38745670
[TBL] [Abstract] [Full Text] [Related]
5. Targeted degradation of oncogenic bcr-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN.
Sun Y; Wang Y; Liu C; Huang Y; Long Q; Ju C; Zhang C; Chen Y
J Nanobiotechnology; 2024 May; 22(1):247. PubMed ID: 38741123
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis.
Willyanto SE; Alimsjah YA; Tanjaya K; Tuekprakhon A; Pawestri AR
Ann Med; 2024 Dec; 56(1):2349796. PubMed ID: 38738799
[TBL] [Abstract] [Full Text] [Related]
7. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
[TBL] [Abstract] [Full Text] [Related]
8. Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions.
Short NJ; Jabbour E; Jain N; Kantarjian H
J Hematol Oncol; 2024 May; 17(1):32. PubMed ID: 38734670
[TBL] [Abstract] [Full Text] [Related]
9. [Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review].
Li JJ; Yue LL; Zeng PY; Wu CY; Chen HL
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):299-302. PubMed ID: 38716604
[TBL] [Abstract] [Full Text] [Related]
10. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
11. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
12. [treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
[No Abstract] [Full Text] [Related]
13. JAK2 as Predictor of Therapeutic Response in Patients with Chronic Myeloid leukemia Treated with Imatinib.
Wijaya I; Bashari MH; Reniarti L; Rahmawati A; Roesli RMA
Dis Markers; 2024; 2024():2906566. PubMed ID: 38716474
[TBL] [Abstract] [Full Text] [Related]
14. Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant cml cells.
Okabe S; Moriyama M; Gotoh A
Med Oncol; 2024 May; 41(6):142. PubMed ID: 38714583
[TBL] [Abstract] [Full Text] [Related]
15. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
[TBL] [Abstract] [Full Text] [Related]
16. Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Bhattarai KR; Mobley RJ; Barnett KR; Ferguson DC; Hansen BS; Diedrich JD; Bergeron BP; Yoshimura S; Yang W; Crews KR; Manring CS; Jabbour E; Paietta E; Litzow MR; Kornblau SM; Stock W; Inaba H; Jeha S; Pui CH; Cheng C; Pruett-Miller SM; Relling MV; Yang JJ; Evans WE; Savic D
Nat Commun; 2024 May; 15(1):3681. PubMed ID: 38693155
[TBL] [Abstract] [Full Text] [Related]
17. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.
Cesana D; Cicalese MP; Calabria A; Merli P; Caruso R; Volpin M; Rudilosso L; Migliavacca M; Barzaghi F; Fossati C; Gazzo F; Pizzi S; Ciolfi A; Bruselles A; Tucci F; Spinozzi G; Pais G; Benedicenti F; Barcella M; Merelli I; Gallina P; Giannelli S; Dionisio F; Scala S; Casiraghi M; Strocchio L; Vinti L; Pacillo L; Draghi E; Cesana M; Riccardo S; Colantuono C; Six E; Cavazzana M; Carlucci F; Schmidt M; Cancrini C; Ciceri F; Vago L; Cacchiarelli D; Gentner B; Naldini L; Tartaglia M; Montini E; Locatelli F; Aiuti A
Nat Commun; 2024 Apr; 15(1):3662. PubMed ID: 38688902
[TBL] [Abstract] [Full Text] [Related]
18. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of cml.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract] [Full Text] [Related]
19. A New Indole Derivative, LWX-473, Overcomes Glucocorticoid Resistance in Jurkat Cells by Activating Mediators of Apoptosis.
Song J; Yang K; Gajendran B; Varier KM; Li W; Liu Q; Rao Q; Hang Y; Shen X; Liu S; Huang L; Xu M; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):163. PubMed ID: 38682179
[TBL] [Abstract] [Full Text] [Related]
20. Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.
Hermans SJF; van Norden Y; Versluis J; Rijneveld AW; van der Holt B; de Weerdt O; Biemond BJ; van de Loosdrecht AA; van der Wagen LE; Bellido M; van Gelder M; van der Velden WJFM; Selleslag D; van Lammeren-Venema D; van der Velden VHJ; de Wreede LC; Postmus D; Pignatti F; Cornelissen JJ
Cancer Med; 2024 May; 13(9):e6756. PubMed ID: 38680089
[TBL] [Abstract] [Full Text] [Related]
[Next]
